BiotechTube
Home/Editas Medicine/Gilmore O’Neill
GO

Gilmore O’Neill

President and Chief Executive Officer

Editas Medicine

Therapeutic Areas

CardiovascularHematologyOncology

Editas Medicine Pipeline

DrugIndicationPhase
EDIT-401Hyperlipidemia and Atherosclerotic Cardiovascular Disease (ASCVD)Pre-clinical
Undisclosed In Vivo ProgramSickle Cell Disease (SCD)Research
Alpha-beta T-cell medicinesOncologyUndisclosed
Gamma-delta T-cell medicinesOncologyUndisclosed

Leadership Team at Editas Medicine

BB
Brieana Buckley
Senior Vice President, Development and Program Leadership
LC
Linda C. Burkly
Executive Vice President and Chief Scientific Officer
DG
Damien Grierson
Senior Vice President and General Counsel
FP
Frank Panaccio
Senior Vice President and Chief Business Officer
AP
Amy Parison
Senior Vice President and Chief Financial Officer
GW
Gregory Whitehead
Executive Vice President and Chief Technical and Quality Officer
View full Editas Medicine profile